Dr. Hongliang Guo 郭洪亮
Chief Physician
Department of Gastric Surgery, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Complex gastrointestinal tumor surgeries, retroperitoneal tumors, and multi-organ resections. Experienced in pelvic nerve-preserving and sphincter-preserving surgery for low rectal cancer, and treatment of malignant gastrointestinal stromal tumors.
Dr. Guo is Chief Physician and Director of the Fourth Surgical Ward (Gastrointestinal Surgery). With over 20 years in gastrointestinal oncologic surgery, Dr. Guo focuses on standardized surgical and comprehensive treatment of digestive tract tumors. Dr. Guo was a Senior Visiting Scholar at the University of Pittsburgh Cancer Institute.
Professional roles
- Member, China Anti-Cancer Association
- Member, National Colorectal Cancer Professional Committee
- Vice Chair, Gastrointestinal Surgery Branch, Shandong Anti-Cancer Association
- Vice Chair, Colorectal Cancer Professional Committee, Shandong Medical Doctor Association
Name order: in Chinese the family name comes first (Guo Hongliang). Papers usually list the name as Hongliang Guo or Guo H.
Selected publications
22 papers on PubMed matched by name and affiliation; 6 as first or senior author since 2016. Most recent first- or senior-author papers:
- Hum Cell, 2022 (senior author): A novel mitochondria-related gene signature for controlling colon cancer cell mitochondrial respiration and proliferation. PubMed 35429326
- Transl Cancer Res, 2021 (senior author): Revealing potential immunotherapy targets through analysis of a ceRNA network in human colon adenocarcinoma. PubMed 35116380
- Exp Cell Res, 2020 (senior author): NT5DC2 knockdown inhibits colorectal carcinoma progression by repressing metastasis, angiogenesis and tumor-associated macrophage recruitment: A mechanism involving VEGF signaling. PubMed 32991874
- Curr Pharm Des, 2020 (senior author): Conditional Reprogramming Inducing Clinical Cells Proliferation: New Research Tools in Tumor and Inflammatory-related Diseases. PubMed 32175833
- Oncotarget, 2018 (senior author): Outcomes of radiation therapy for resectable M0 gastric cancer. PubMed 29416726
- Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2016 (senior author): [Keratin 18 phosphorylation increases autophagy of colorectal cancer HCT116 cells and enhanced its sensitivity to oxaliplatin]. PubMed 26728375
- World J Surg Oncol, 2015 (senior author): Gallbladder perforation: a rare complication of postoperative chemotherapy of gastric cancer. PubMed 26271278
- Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2015 (senior author): [ASPP2 inhibits oxaliplatin-induced autophagy and promotes apoptosis of colon cancer cells]. PubMed 26146058
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion